Clinical observations on treating Alzheimer's disease with umbilical cord blood mononuclear cells

View Full Paper

Ask AI

Bookmark

Intravenous infusion of UCBMCs leads to temporary improvements in cognitive function for Alzheimer's patients, enhancing their daily living activities.
Substantial changes in MMSE, ADAS-Cog, ADL, and PSQI scores were observed at various time points, demonstrating treatment effects.
Repeated measures ANOVA showed significant differences across evaluation periods, hinting at varying effects over time.
Treatment was associated with a high safety profile and indicates the potential for hUCBMCs as a therapeutic option in Alzheimer's management.

Discussion

No takes yet. Share an insight, caveat, or question.

Observational analysis shows improvement in cognitive function and daily activities in Alzheimer's patients, indicating potential treatment benefits.

Chen et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Observational analysis shows improvement in cognitive function and daily activities in Alzheimer's patients, indicating potential treatment benefits.